Actualización de las recomendaciones para médicos y pacientes. | 31 JUL 17

Cribado del cáncer colorrectal

El cribado del cáncer colorrectal es el protocolo del proceso de detección del cáncer y de lesiones pre-cancerosas en personas asintomáticas sin antecedentes
Autor/a: Douglas K. Rex, C. Richard Boland, Jason A. Dominitz y colaboradores.  Am J Gastroenterol. 2017 Jul;112(7):1016-1030
INDICE:  1. Página 1 | 2. Referencias bilibiográficas
Referencias bilibiográficas

1. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology 2008; 134: 1570 – 95.

2. Kahi CJ, Boland CR, Dominitz JA et al. Colonoscopy surveillance aft er colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastrointest Endosc 2016; 83: 489 – 98.

3. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance aft er screening and polypectomy. Gastroenterology 2012; 143: 844 – 57.

4. Levin TR, Jamieson L, Burley DA et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011; 33: 101 – 10.

5. Zavoral M, Suchanek S, Zavada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907 – 15.

6. Cenin DR, St John DJB, Ledger MJN et al. Optimizing the expansion of the National Bowel Cancer Screening Program. Med J Aust 2014; 201: 456 – 61.

7. Jensen CD, Corley DA, Quinn VP et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016; 164: 456 – 63.

8. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012; 21: 411 – 6.

9. Klabunde CN, Joseph DA, King JB et al. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR 2013; 62: 881 – 8.

10. Sabatino SS, White MC, Th ompson TT et al. Cancer screening test use—United States, 2013. MMWR 2015; 64: 464 – 8.

11. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104 – 17.

12. Edwards BK, Noone AM, Mariotto AB et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014; 120: 1290 – 314.

13. Liang PS, Wheat CL, Abhat A et al. Adherence to competing strategies for colorectal cancer screening over 3 years. Am J Gastroenterol 2016; 111: 105 – 14.

14. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2016; 315: 2564 – 75.

15. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012; 172: 575 – 82.

16. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005; 97:147 – 57.

17. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006; 184: 546 – 50.

18. Scott RG, Edwards JT, Fritschi L et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 2004; 99:1145 – 51.

19. Griffi th JM, Lewis CL, Brenner ART et al. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Dec Mak 2008; 8:4.

20. Canadian Task Force on Preventive Health Care. Recommendations on screening for colorectal cancer in primary care. CMAJ 2016; 188: 340 – 8.

21. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening. Am J Gastroenterol 2009; 104: 739 – 50.

22. ASGE Standards of Practice Committee, Davila RE, Rajan E et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546 – 57.

23. Senore C, Ederle A, Benazzato L et al. Offering people a choice for colorectal cancer screening. Gut 2013; 62: 735 – 40.

24. Symonds EL, Pedersen S, Cole SR et al. Improving participation in colorectal cancer screening: a randomized controlled trial of sequential offers of fecal then blood based non-invasive tests. Asian Pac J Cancer Prev 2015; 16: 8455 – 60. 25. Adler A, Geiger S, Keil A et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol 2014; 14: 183. 26. Rex D. Colonoscopy: the current king of the hill in the USA.  Dig Dis Sci 2015; 60: 639 – 46.

27. Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol 2014; 12: 1624 – 34.

28. Imperiale TF, Monahan PO, Stump TE et al. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med 2015; 163: 339 – 46.

29. Chiu HM, Ching JY, Wu KC et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology 2016; 150: 617 – 25.

30. Winawer SJ, Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. Th e National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977 – 81.

31. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687 – 96.

32. Brenner H, Hoffmeister M, Stegmaier C et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007; 56: 1585 – 9.

33. Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum:  review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315 – 29

1. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology 2008; 134: 1570 – 95.

2. Kahi CJ, Boland CR, Dominitz JA et al. Colonoscopy surveillance aft er colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastrointest Endosc 2016; 83: 489 – 98.

3. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance aft er screening and polypectomy. Gastroenterology 2012; 143: 844 – 57.

4. Levin TR, Jamieson L, Burley DA et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011; 33: 101 – 10.

5. Zavoral M, Suchanek S, Zavada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907 – 15.

6. Cenin DR, St John DJB, Ledger MJN et al. Optimizing the expansion of the National Bowel Cancer Screening Program. Med J Aust 2014; 201: 456 – 61.

7. Jensen CD, Corley DA, Quinn VP et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016; 164: 456 – 63.

8. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012; 21: 411 – 6.

9. Klabunde CN, Joseph DA, King JB et al. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR 2013; 62: 881 – 8.

10. Sabatino SS, White MC, Th ompson TT et al. Cancer screening test use— United States, 2013. MMWR 2015; 64: 464 – 8.

11. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014.CA Cancer J Clin 2014; 64: 104 – 17.

12. Edwards BK, Noone AM, Mariotto AB et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014; 120: 1290 – 314.

13. Liang PS, Wheat CL, Abhat A et al. Adherence to competing strategies for colorectal cancer screening over 3 years. Am J Gastroenterol 2016; 111: 105 – 14.

14. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2016; 315: 2564 – 75.

15. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012; 172: 575 – 82.

16. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005; 97: 147 – 57.

17. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006; 184: 546 – 50.

18. Scott RG, Edwards JT, Fritschi L et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 2004; 99: 1145 – 51.

19. Griffi th JM, Lewis CL, Brenner ART et al. Th e effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Dec Mak 2008; 8: 4.

20. Canadian Task Force on Preventive Health Care. Recommendations on screening for colorectal cancer in primary care. CMAJ 2016; 188: 340 – 8.

21. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening. Am J Gastroenterol 2009; 104: 739 – 50.

22. ASGE Standards of Practice Committee, Davila RE, Rajan E et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546 – 57.

23. Senore C, Ederle A, Benazzato L et al. Offering people a choice for colorectal cancer screening. Gut 2013; 62: 735 – 40.

24. Symonds EL, Pedersen S, Cole SR et al. Improving participation in colorectal cancer screening: a randomized controlled trial of sequential offers of fecal then blood based non-invasive tests. Asian Pac J Cancer Prev 2015; 16: 8455 – 60.

25. Adler A, Geiger S, Keil A et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol 2014; 14: 183.

26. Rex D. Colonoscopy: the current king of the hill in the USA. Dig Dis Sci 2015; 60: 639 – 46.

27. Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol 2014; 12: 1624 – 34.

28. Imperiale TF, Monahan PO, Stump TE et al. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med 2015; 163: 339 – 46.

29. Chiu HM, Ching JY, Wu KC et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology 2016; 150: 617 – 25.

30. Winawer SJ, Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. Th e National Polyp Study Workgroup.

N Engl J Med 1993; 329: 1977 – 81.

31. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687 – 96.

32. Brenner H, Hoffmeister M, Stegmaier C et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007; 56: 1585 – 9.

33. Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315 – 29

58. Doubeni CA, Weinmann S, Adams K et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 2013; 158: 312 – 20.

59. Brenner H, Chang-Claude J, Jansen L et al. Reduced risk of colorectal cancer up to 10 years aft er screening, surveillance or diagnostic colonoscopy . Gastroenterology 2014; 146: 709 – 17.

60. Mulder SA, van Soest EM, Dieleman JP et al. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol 2010; 22: 437 – 43.

61. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Inern Med 2009; 150: 1 – 8.

62. Baxter NN, Warren JL, Barrett MJ et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012; 30: 2664 – 9.

63. Nishihara R, Wu K, Lochhead P et al. Long-term colorectal cancer incidence and mortality aft er lower endoscopy. N Engl J Med 2013; 369: 1095 – 105.

64. Doubeni CA, Corley DA, Quinn VP et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. Epub 2016; http://dx.doi. org/l0.1136/gutjnl-2016-312712.

65. Mandel JS, Church TR, Bond JH. Th e effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603 – 7.

66. Schoen RE, Pinsky PF, Weissfeld JL et al. Colorectal-cancer incidence and mortality with fl exible sigmoidoscopy. N Engl J Med 2012; 366: 2345 – 57.

67. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795 – 803.

68. Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298 – 306.

69. Cooper GS, Kou TD, Rex DK. Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med 2013; 173: 551 – 6.

70. Reumkens A, Ronadagh EJ. Bakker, et al. Post-colonoscopy complications: A systematic review, time trends, and meta-analysis of population based studies. Am J Gastroenterol 2016; 111: 1092 – 101.

71. Bahin FF, Rasouli KN, Byth K et al. Prediction of clinically signifi cant bleeding following wide-fi eld endoscopic resection of large sessile and laterally spreading colorectal lesions: a clinical risk score. Am J Gastroenterol 2016; 111: 1115 – 22.

72. Ichise Y, Horiuchi A, Nakayama Y et al. Prospective randomized comparison of cold snare polypectomy and conventional polypectomy for small colorectal polyps. Digestion 2011; 84: 78 – 81.

73. Jayanna M, Burgess NG, Singh R et al. Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions. Clin Gastroenterol Hepatol 2016; 14: 271 – 8.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024